These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1547795)

  • 1. The management in ovarian cancer at the First Dept. of Obstetrics and Gynecology, University of Vienna.
    Gitsch E; Salzer H
    Eur J Gynaecol Oncol; 1992; 13(1):61-4. PubMed ID: 1547795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress in the management of ovarian cancer at the First Department of Obstetrics and Gynecology, University of Vienna, since 1955.
    Gitsch E; Salzer H
    Verh K Acad Geneeskd Belg; 1993; 55(2):145-9. PubMed ID: 8480450
    [No Abstract]   [Full Text] [Related]  

  • 3. [Common history and prospects in surgical gynecology of the Charité and the Vienna University Clinic].
    Gitsch E
    Gynakol Geburtshilfliche Rundsch; 1995; 35(3):164-8. PubMed ID: 7496184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment and prognostic analysis of ovarian cancer patients with isolated region of lymph node recurrence].
    Tu H; Huang H; Huang QD; Li Z; Feng YL; Liu JH
    Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):928-33. PubMed ID: 23324194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors in ovarian cancer.
    Rakar S; Kovacic J; Cavic M; Lukanovic A; Mozina A
    Eur J Gynaecol Oncol; 1990; 11(3):171-3. PubMed ID: 2170137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. National survey of ovarian carcinoma. VI. Critical assessment of current International Federation of Gynecology and Obstetrics staging system.
    Nguyen HN; Averette HE; Hoskins W; Sevin BU; Penalver M; Steren A
    Cancer; 1993 Nov; 72(10):3007-11. PubMed ID: 8221569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Annual report of Gynecologic Oncology Committee, Japan Society of Obstetrics and Gynecology, 2013.
    Aoki D
    J Obstet Gynaecol Res; 2014 Feb; 40(2):338-48. PubMed ID: 24472052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant transformation of ovarian mature cystic teratoma.
    Rim SY; Kim SM; Choi HS
    Int J Gynecol Cancer; 2006; 16(1):140-4. PubMed ID: 16445624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intensive Care Labor and Delivery Unit at the University Hospital, Vienna, Austria.
    Neumark J; Baumgarten K; Clark RB
    J Ark Med Soc; 1977 Nov; 74(6):221-4. PubMed ID: 144107
    [No Abstract]   [Full Text] [Related]  

  • 10. [The development of Obstetrics at the 2nd Department of Obstetrics and Gynecology, University of Vienna, Medical School, during the last 20 years (author's transl)].
    Fröhlich H
    Wien Klin Wochenschr; 1978 Aug; 90(15):545-50. PubMed ID: 354219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Annual report of the Committee on Gynecologic Oncology, the Japan Society of Obstetrics and Gynecology.
    Yamagami W; Aoki D
    J Obstet Gynaecol Res; 2015 Feb; 41(2):167-77. PubMed ID: 25370711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognosis and management of borderline tumours of the ovary.
    Tropé C; Kaern J
    Curr Opin Obstet Gynecol; 1996 Feb; 8(1):12-6. PubMed ID: 8777251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome and clinical management of 275 patients with advanced ovarian cancer International Federation of Obstetrics and Gynecology II to IV inside the European Ovarian Cancer Translational Research Consortium-OVCAD.
    Chekerov R; Braicu I; Castillo-Tong DC; Richter R; Cadron I; Mahner S; Woelber L; Marth C; Van Gorp T; Speiser P; Zeillinger R; Vergote I; Sehouli J
    Int J Gynecol Cancer; 2013 Feb; 23(2):268-75. PubMed ID: 23358178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment and prognostic factors for stage IV epithelial ovarian cancer].
    Wu M; Shen K; Lang J
    Zhonghua Fu Chan Ke Za Zhi; 2000 Apr; 35(4):200-3. PubMed ID: 11776158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic SIGNIFICANCE of Cytoreductive Therapy of Ovarian Cancer - eastern Croatia experience.
    Topolovec Z; Horvat T; Vidosavljević D; Šijanović S; Müller-Vranješ A; Ugljarević M; Milojković D; Topolovec S
    Acta Clin Croat; 2019 Jun; 58(2):311-320. PubMed ID: 31819328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Historical development of the Radiology Department of the 1st and 2d University Women's Hospital Vienna].
    Gitsch E
    Wien Med Wochenschr; 1990 Oct; 140(20):495-7. PubMed ID: 2264351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-Term Survival for Platinum-Sensitive Recurrent Ovarian Cancer Patients Treated with Secondary Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy (HIPEC).
    Petrillo M; De Iaco P; Cianci S; Perrone M; Costantini B; Ronsini C; Scambia G; Fagotti A
    Ann Surg Oncol; 2016 May; 23(5):1660-5. PubMed ID: 26714958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization and Management of Borderline Ovarian Tumors - Results of a Retrospective, Single-center Study of Patients Treated at the Department of Gynecology and Obstetrics of the University Medicine Greifswald.
    Koensgen D; Weiss M; Assmann K; Brucker SY; Wallwiener D; Stope MB; Mustea A
    Anticancer Res; 2018 Mar; 38(3):1539-1545. PubMed ID: 29491083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Borderline epithelial ovarian tumours.
    Ayhan A; Akarin R; Develioglu O; Yarali H; Kücükali T; Bilgin F
    Aust N Z J Obstet Gynaecol; 1991 May; 31(2):174-6. PubMed ID: 1930041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival rates for international federation of gynecology and obstetrics stage III ovarian carcinoma by cell type: a study of 262 unselected patients with uniform pathologic review.
    Seidman JD; Yemelyanova A; Cosin JA; Smith A; Kurman RJ
    Int J Gynecol Cancer; 2012 Mar; 22(3):367-71. PubMed ID: 22237384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.